Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludwig Plasswilm

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Radiation Oncology (London, England)|July 12, 2014
A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipseSamuel Peters, Hans Schiefer, Ludwig Plasswilm
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 2, 2014
Surface dose characterisation of the Varian Ir-192 HDR conical surface applicator set with a vertically orientated sourceKonrad Buchauer, Guido Henke, Hans Schiefer, et al.
Radiation Oncology (London, England)|July 16, 2020
Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic reviewAlexandra Hendrickx, Antonio Cozzio, Ludwig Plasswilm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2004
Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitroNils Cordes, Christina Beinke, Ludwig Plasswilm, et al.
Radiation Oncology (London, England)|December 11, 2012
Compensability index for compensation radiotherapy after treatment interruptionsPaul Martin Putora, Michael Schmuecking, Daniel Aebersold, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 11, 2002
[Positioning accuracy in conformational prostatic irradiation using portal imaging]Annemarie Bakai, Frank Paulsen, Ludwig Plasswilm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 20, 2015
Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparisonHans Schiefer, Konrad Buchauer, Simon Heinze, et al.
Therapeutische Umschau. Revue Therapeutique|September 10, 2019
[Modern Treatment Concepts in Radiation Oncology]Ludwig Plasswilm, Gabriela Studer, Daniel M Aebersold, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 14, 2004
Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicityAntje Ernst-Stecken, Gerhard Grabenbauer, Heinrich Iro, et al.
Onkologie|April 4, 2013
Relevance of incidental colorectal FDG-PET/CT-enhanced lesionsPaul M Putora, Joachim Müller, Jan Borovicka, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Radiation Oncology (London, England)|July 12, 2014
A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipseSamuel Peters, Hans Schiefer, Ludwig Plasswilm
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 2, 2014
Surface dose characterisation of the Varian Ir-192 HDR conical surface applicator set with a vertically orientated sourceKonrad Buchauer, Guido Henke, Hans Schiefer, et al.
Radiation Oncology (London, England)|July 16, 2020
Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic reviewAlexandra Hendrickx, Antonio Cozzio, Ludwig Plasswilm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2004
Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitroNils Cordes, Christina Beinke, Ludwig Plasswilm, et al.
Radiation Oncology (London, England)|December 11, 2012
Compensability index for compensation radiotherapy after treatment interruptionsPaul Martin Putora, Michael Schmuecking, Daniel Aebersold, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 11, 2002
[Positioning accuracy in conformational prostatic irradiation using portal imaging]Annemarie Bakai, Frank Paulsen, Ludwig Plasswilm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 20, 2015
Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparisonHans Schiefer, Konrad Buchauer, Simon Heinze, et al.
Therapeutische Umschau. Revue Therapeutique|September 10, 2019
[Modern Treatment Concepts in Radiation Oncology]Ludwig Plasswilm, Gabriela Studer, Daniel M Aebersold, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 14, 2004
Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicityAntje Ernst-Stecken, Gerhard Grabenbauer, Heinrich Iro, et al.
Onkologie|April 4, 2013
Relevance of incidental colorectal FDG-PET/CT-enhanced lesionsPaul M Putora, Joachim Müller, Jan Borovicka, et al.
Pageof 6